rediff.com

News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Sign in  |  Create a Rediffmail account

Wanbury

Subscribe via RSS
Rediff.com  »  News  »   Wanbury

  News for Wanbury

  • Business

'Few FCCB re-pay options for India Inc'

 Only five Indian companies would be in a position to choose most available redemption options for their foreign currency convertible bonds (FCCBs), due for redemption this year, according to a......

Wanbury eyes contract research firms in US

 Wanbury, the largest global manufacturer of diabetes management drug metformin, plans to acquire contract research and manufacturing servicescompanies in the US and Europe.Wanbury, which entered......

5 stocks worth investing in

 The Indian markets had fallen by almost 30 per cent between January and March, 2008. Since then, they have recovered half the lost ground. The impact of the fall was so hard that many stocks were......

Teva sues Indian pharma cos

 Teva Pharmaceutical Industries Ltd has sued Indian drug makers, including Ranbaxy Laboratories and Dr Reddy's, for alleged patent violation of ingredients used in Coreg, used for treatment of......

Wanbury to buy generic biz of Spanish Co

 Pharma company Wanbury Ltd on Monday said it will acquire the branded generic business of Spain-based Industrial Farmaceutica Cantabria through Cantabria Pharma SL for 50 million Euro. The board of......

Top Coverage News

World Test Championship 2023

 India held the top position in the ICC Men's Test Team Rankings while Australia secured the...

Manipur's Tragedy

 Here are news, updates and coverage from violence hit Manipur.

IPL 2023

 Complete coverage of IPL 2023

Sri Lanka's Tour of India 2023

 Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.

GUJARAT, HIMACHAL GO TO POLLS

 The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
rediff on the net© 2024 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Feedback - About us | Terms of use - Grievances